Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
All 608 Biotechnology stocks listed, ranked by market capitalization — 13 page(s), 50 per page. The 1 company with no market capitalization available follows the ranking.
What Are the Leading Biotechnology Stocks?
Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026There are 608 publicly traded Biotechnology stocks. The largest by market capitalization are VRTX, MRNA, REGN, ARGX, ONC, RVMD, RPRX, ALNY, ROIV, GMAB.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | VRTX | $524.52 | $132.95B | 30.4 | — |
| Moderna, Inc. | MRNA | $245.81 | $98.14B | — | |
| Regeneron Pharmaceuticals, Inc. | REGN | $805.67 | $82.95B | 19.9 | 0.47% |
| argenx SE | ARGX | $890.05 | $55.97B | 33.9 | — |
| BeOne Medicines AG | ONC | $386.46 | $43.97B | 69.1 | — |
| Revolution Medicines, Inc. | RVMD | $194.28 | $41.64B | — | |
| Royalty Pharma plc | RPRX | $62.15 | $35.91B | 33.1 | 1.51% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $225.10 | $30.12B | 38.0 | — |
| Roivant Sciences Ltd. | ROIV | $36.80 | $26.58B | — | |
| Genmab A/S | GMAB | $39.57 | $24.33B | 31.2 | — |
| Incyte Corporation | INCY | $113.44 | $22.99B | 14.5 | — |
| BioNTech SE | BNTX | $91.29 | $22.66B | — | |
| Insmed Incorporated | INSM | $94.04 | $20.54B | — | |
| Exelixis, Inc. | EXEL | $64.58 | $16.00B | 20.4 | — |
| Ascendis Pharma A/S | ASND | $238.90 | $15.72B | 18.0 | — |
| Halozyme Therapeutics, Inc. | HALO | $124.83 | $14.17B | 36.5 | — |
| Jazz Pharmaceuticals plc | JAZZ | $211.97 | $13.76B | 14.5 | — |
| BridgeBio Pharma, Inc. | BBIO | $67.74 | $12.98B | — | |
| Summit Therapeutics Inc. | SMMT | $15.83 | $12.63B | — | |
| Corcept Therapeutics Incorporated | CORT | $116.28 | $12.57B | 258.4 | — |
| Bio-Techne Corporation | TECH | $72.64 | $11.39B | 62.6 | 0.44% |
| BioMarin Pharmaceutical Inc. | BMRN | $55.21 | $10.69B | 149.2 | — |
| Madrigal Pharmaceuticals, Inc. | MDGL | $457.96 | $10.58B | — | |
| Vaxcyte, Inc. | PCVX | $63.23 | $9.95B | — | |
| Twist Bioscience Corporation | TWST | $149.13 | $9.89B | — | |
| Krystal Biotech, Inc. Common Stock | KRYS | $322.17 | $9.54B | 40.4 | — |
| Kymera Therapeutics, Inc. | KYMR | $112.63 | $9.26B | — | |
| ImmunityBio, Inc. | IBRX | $8.64 | $9.16B | — | |
| Protagonist Therapeutics, Inc. | PTGX | $138.08 | $8.93B | 134.1 | — |
| Cytokinetics, Incorporated | CYTK | $62.86 | $8.74B | — | |
| Spyre Therapeutics, Inc. | SYRE | $92.95 | $8.69B | — | |
| Axsome Therapeutics, Inc. | AXSM | $156.31 | $8.36B | — | |
| Caris Life Sciences, Inc. | CAI | $32.35 | $8.35B | 17.5 | — |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $58.84 | $8.31B | — | |
| ABIVAX Société Anonyme | ABVX | $93.49 | $8.16B | — | |
| TG Therapeutics, Inc. | TGTX | $53.20 | $8.14B | 19.4 | — |
| Ionis Pharmaceuticals, Inc. | IONS | $44.27 | $7.36B | — | |
| Praxis Precision Medicines, Inc. | PRAX | $256.47 | $7.16B | — | |
| Iovance Biotherapeutics, Inc. | IOVA | $14.62 | $6.62B | — | |
| Ligand Pharmaceuticals Incorporated | LGND | $314.78 | $6.28B | 33.2 | — |
| Belite Bio, Inc | BLTE | $153.18 | $6.15B | — | |
| Rhythm Pharmaceuticals, Inc. Common Stock | RYTM | $88.62 | $6.10B | — | |
| Immunovant, Inc. | IMVT | $28.38 | $5.86B | — | |
| Veradermics, Incorporated | MANE | $136.66 | $5.71B | — | |
| CG Oncology, Inc. | CGON | $62.24 | $5.53B | — | |
| Kodiak Sciences Inc. | KOD | $87.72 | $5.51B | — | |
| Cogent Biosciences, Inc. | COGT | $31.43 | $5.45B | — | |
| Mirum Pharmaceuticals, Inc. | MIRM | $83.44 | $5.42B | — | |
| Oruka Therapeutics, Inc. | ORKA | $79.92 | $5.29B | — | |
| Scholar Rock Holding Corporation | SRRK | $43.00 | $5.24B | — |
Vertex Pharmaceuticals Incorporated
Healthcare / Biotechnology
- Market Cap
- $132.95B
- P/E
- 30.4
Moderna, Inc.
Healthcare / Biotechnology
- Market Cap
- $98.14B
- P/E
- unprofitable
Regeneron Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $82.95B
- P/E
- 19.9
- Dividend Yield
- 0.47%
argenx SE
Healthcare / Biotechnology
- Market Cap
- $55.97B
- P/E
- 33.9
BeOne Medicines AG
Healthcare / Biotechnology
- Market Cap
- $43.97B
- P/E
- 69.1
Revolution Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $41.64B
- P/E
- unprofitable
Royalty Pharma plc
Healthcare / Biotechnology
- Market Cap
- $35.91B
- P/E
- 33.1
- Dividend Yield
- 1.51%
Alnylam Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $30.12B
- P/E
- 38.0
Roivant Sciences Ltd.
Healthcare / Biotechnology
- Market Cap
- $26.58B
- P/E
- unprofitable
Genmab A/S
Healthcare / Biotechnology
- Market Cap
- $24.33B
- P/E
- 31.2
Incyte Corporation
Healthcare / Biotechnology
- Market Cap
- $22.99B
- P/E
- 14.5
BioNTech SE
Healthcare / Biotechnology
- Market Cap
- $22.66B
- P/E
- unprofitable
Insmed Incorporated
Healthcare / Biotechnology
- Market Cap
- $20.54B
- P/E
- unprofitable
Exelixis, Inc.
Healthcare / Biotechnology
- Market Cap
- $16.00B
- P/E
- 20.4
Ascendis Pharma A/S
Healthcare / Biotechnology
- Market Cap
- $15.72B
- P/E
- 18.0
Halozyme Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.17B
- P/E
- 36.5
Jazz Pharmaceuticals plc
Healthcare / Biotechnology
- Market Cap
- $13.76B
- P/E
- 14.5
BridgeBio Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $12.98B
- P/E
- unprofitable
Summit Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $12.63B
- P/E
- unprofitable
Corcept Therapeutics Incorporated
Healthcare / Biotechnology
- Market Cap
- $12.57B
- P/E
- 258.4
Bio-Techne Corporation
Healthcare / Biotechnology
- Market Cap
- $11.39B
- P/E
- 62.6
- Dividend Yield
- 0.44%
BioMarin Pharmaceutical Inc.
Healthcare / Biotechnology
- Market Cap
- $10.69B
- P/E
- 149.2
Madrigal Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $10.58B
- P/E
- unprofitable
Vaxcyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.95B
- P/E
- unprofitable
Twist Bioscience Corporation
Healthcare / Biotechnology
- Market Cap
- $9.89B
- P/E
- unprofitable
Krystal Biotech, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $9.54B
- P/E
- 40.4
Kymera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.26B
- P/E
- unprofitable
ImmunityBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $9.16B
- P/E
- unprofitable
Protagonist Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.93B
- P/E
- 134.1
Cytokinetics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $8.74B
- P/E
- unprofitable
Spyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.69B
- P/E
- unprofitable
Axsome Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.36B
- P/E
- unprofitable
Caris Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.35B
- P/E
- 17.5
Arrowhead Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.31B
- P/E
- unprofitable
ABIVAX Société Anonyme
Healthcare / Biotechnology
- Market Cap
- $8.16B
- P/E
- unprofitable
TG Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $8.14B
- P/E
- 19.4
Ionis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.36B
- P/E
- unprofitable
Praxis Precision Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $7.16B
- P/E
- unprofitable
Iovance Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.62B
- P/E
- unprofitable
Ligand Pharmaceuticals Incorporated
Healthcare / Biotechnology
- Market Cap
- $6.28B
- P/E
- 33.2
Belite Bio, Inc
Healthcare / Biotechnology
- Market Cap
- $6.15B
- P/E
- unprofitable
Rhythm Pharmaceuticals, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $6.10B
- P/E
- unprofitable
Immunovant, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.86B
- P/E
- unprofitable
Veradermics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $5.71B
- P/E
- unprofitable
CG Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.53B
- P/E
- unprofitable
Kodiak Sciences Inc.
Healthcare / Biotechnology
- Market Cap
- $5.51B
- P/E
- unprofitable
Cogent Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.45B
- P/E
- unprofitable
Mirum Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.42B
- P/E
- unprofitable
Oruka Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.29B
- P/E
- unprofitable
Scholar Rock Holding Corporation
Healthcare / Biotechnology
- Market Cap
- $5.24B
- P/E
- unprofitable
Showing 1–50 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Biotechnology Stocks Are Reasonably Valued?
Prices: Oct 21, 2026 closeAmong the 50 largest Biotechnology companies, Incyte Corporation (INCY) trades at the lowest trailing P/E ratio, 14.5. The industry average is 37.1.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Incyte Corporation | INCY | $113.44 | $22.99B | 14.5 | — |
| Jazz Pharmaceuticals plc | JAZZ | $211.97 | $13.76B | 14.5 | — |
| Caris Life Sciences, Inc. | CAI | $32.35 | $8.35B | 17.5 | — |
| Ascendis Pharma A/S | ASND | $238.90 | $15.72B | 18.0 | — |
| TG Therapeutics, Inc. | TGTX | $53.20 | $8.14B | 19.4 | — |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 50 largest Biotechnology companies by market capitalization.
Key facts
As of October 21, 2026, 608 Biotechnology stocks are listed: 591 on NYSE & NASDAQ, 10 on TSX (Toronto Stock Exchange), and 7 on other venues. A company listed on more than one exchange is counted once.
The largest by market capitalization is Vertex Pharmaceuticals Incorporated (VRTX) at $132.95B.
The median P/E across the Biotechnology industry is 16.6.
Biotechnology Industry Overview
From the data · Oct 21, 2026The Biotechnology industry, part of the Healthcare sector, includes 608 publicly traded companies with a combined market capitalization of $1.29T in US dollars. A further CA$1.00B is quoted in CAD, across 10 listed companies. The industry is led by Vertex Pharmaceuticals Incorporated (VRTX), Moderna, Inc. (MRNA), Regeneron Pharmaceuticals, Inc. (REGN).
Among the 608 listed Biotechnology companies, market capitalizations range from $132.95B (Vertex Pharmaceuticals Incorporated) down to $18.24K (CDT Equity Inc.), highlighting the wide size disparity across the industry.
Biotechnology Industry Valuation
The Biotechnology industry currently trades at an average price-to-earnings (P/E) ratio of 37.1. This elevated multiple indicates that investors are pricing in strong future earnings growth across Biotechnology companies. Note that some companies in the industry report no P/E ratio, typically because they are currently unprofitable or in early growth stages.
Biotechnology Dividend Profile
5 out of 608 Biotechnology companies (1%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Biotechnology stocks is 1.83%. Most Biotechnology companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Frequently Asked Questions
What are the leading Biotechnology stocks?
The largest Biotechnology stocks by market capitalization are Vertex Pharmaceuticals Incorporated (VRTX), Moderna, Inc. (MRNA), Regeneron Pharmaceuticals, Inc. (REGN), argenx SE (ARGX), BeOne Medicines AG (ONC). The ranking by market cap on this page covers 607 of the 608 companies. The 1 company with no market capitalization available follows the ranking.
Where can I find a complete list of Biotechnology stocks?
This page is the complete list: 608 Biotechnology companies across 13 page(s), 50 per page, ranked by market capitalization — including VRTX, MRNA, REGN, ARGX, ONC. The 1 company with no market capitalization available follows the ranking.
How many Biotechnology stocks are there?
There are 608 publicly traded Biotechnology companies: 591 on NYSE & NASDAQ, 10 on TSX (Toronto Stock Exchange), and 7 on other venues. By market capitalization, they range from Vertex Pharmaceuticals Incorporated (VRTX) to CDT Equity Inc. (CDT). A company listed on more than one exchange is counted once. This directory spans 13 pages, with all companies sorted by market cap for easy comparison. The 1 company with no market capitalization available follows the ranking.
Which Biotechnology stocks are reasonably valued?
Among the 50 largest Biotechnology companies, Incyte Corporation (INCY) carries the lowest trailing P/E at 14.4, against an industry average of 37.1.
Which Biotechnology stocks have the highest dividend yield?
5 of the 608 Biotechnology companies (1%) pay a dividend, with an average yield of 1.83% among payers. The highest yield among the 50 largest is Royalty Pharma plc (RPRX) at 1.51%.
Explore Biotechnology Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 608 Biotechnology companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Biotechnology stocks head to head. All data is updated regularly to reflect the latest available financials.